부산대학교 도서관

Mochmann LH; Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Treue D; Institute of Pathology Berlin, Charité - Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Berlin, Germany.; Bockmayr M; Institute of Pathology Berlin, Charité - Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Berlin, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Silva P; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Zasada C; Berlin Institute for Medical Systems Biology (BIMSB) at Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Mastrobuoni G; Berlin Institute for Medical Systems Biology (BIMSB) at Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Bayram S; Berlin Institute for Medical Systems Biology (BIMSB) at Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Forbes M; Berlin Institute for Medical Systems Biology (BIMSB) at Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Jurmeister P; Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Liebig S; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Blau O; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Schleich K; Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.; Splettstoesser B; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Bavaria, Germany.; Nordmann TM; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Bavaria, Germany.; von der Heide EK; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Isaakidis K; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Schulze V; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Busch C; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Siddiq H; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Schlee C; Department of Hematology and Oncology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Campus Benjamin Franklin, Berlin, Germany.; Hester S; Department of Biochemistry, Oxford University, Oxford, UK.; Fransecky L; Department of Hematology and Oncology, UKSH, Campus Kiel, Kiel, Germany.; Neumann M; Department of Hematology and Oncology, UKSH, Campus Kiel, Kiel, Germany.; Kempa S; Berlin Institute for Medical Systems Biology (BIMSB) at Max Delbruck Center for Molecular Medicine, Berlin, Germany. Stefan.Kempa@mdc-berlin.de.; Klauschen F; Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany. Frederick.Klauschen@med.uni-muenchen.de.; Institute of Pathology Berlin, Charité - Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin, Humboldt-Universität, and Berlin Institute of Health, Berlin, Germany. Frederick.Klauschen@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany. Frederick.Klauschen@med.uni-muenchen.de.; Baldus CD; Department of Hematology and Oncology, UKSH, Campus Kiel, Kiel, Germany. Claudia.Baldus@uksh.de.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE

Neumann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. m.neumann@uksh.de.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany. m.neumann@uksh.de.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany. m.neumann@uksh.de.; Beder T; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.; Bastian L; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.; Hänzelmann S; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Bultmann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.; Wolgast N; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.; Hartmann A; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.; Trautmann H; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.; Ortiz-Tanchez J; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.; Schlee C; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.; Schroeder M; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.; Fransecky L; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.; Vosberg S; Department of Internal Medicine III, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fiedler W; Medical Department II, Hematology and Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany.; Alakel N; Medical Department I, Carl Gustav Carus University Hospital Dresden, Dresden, Germany.; Heberling L; Medical Department I, Carl Gustav Carus University Hospital Dresden, Dresden, Germany.; Kondakci M; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.; Starck M; Medical Department I, Hospital München-Schwabing, Schwabing, Germany.; Schwartz S; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.; Raffel S; Medical Department V, University Hospital Heidelberg, Heidelberg, Germany.; Müller-Tidow C; Medical Department V, University Hospital Heidelberg, Heidelberg, Germany.; Schneller F; Medical Department III, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.; Reichle A; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.; Burmeister T; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.; Greif PA; Department of Internal Medicine III, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Brüggemann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.; Gökbuget N; Department of Medicine II, Hematology/Oncology, University Hospital, Goethe University, Frankfurt/M, Germany.; Baldus CD; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Röllig C; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany.; Ruhnke L; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Fransecky L; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Heydrich BN; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Hanoun M; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Noppeney R; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Schäfer-Eckart K; Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany.; Wendelin K; Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany.; Mikesch JH; Department of Medicine A, University Hospital Münster, Münster, Germany.; Middeke JM; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Reimann M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Fiebig F; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Zukunft S; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Wermke M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Serve H; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany.; Platzbecker U; Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.; Müller-Tidow C; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.; Baldus CD; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Bornhäuser M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases Dresden, Dresden, Germany.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Ravandi F; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.; Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Research, Gene Center, LMU Munich, Munich, Germany.; Walter RB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Vachhani P; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Ossenkoppele G; Amsterdam University Medical Center, Amsterdam, The Netherlands.; Buecklein V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Research, Gene Center, LMU Munich, Munich, Germany.; Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.; Baldus CD; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.; Fransecky L; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany.; Pardee TS; Department of Internal Medicine, Section on Hematology and Oncology, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA.; Kantarjian H; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.; Yen PK; Amgen Inc, Thousand Oaks, CA, USA.; Mukundan L; Amgen Inc, South San Francisco, CA, USA.; Panwar B; Amgen Inc, South San Francisco, CA, USA.; Yago MR; Amgen Inc, South San Francisco, CA, USA.; Agarwal S; Amgen Inc, Thousand Oaks, CA, USA.; Khaldoyanidi SK; Amgen Inc, Thousand Oaks, CA, USA.; Stein A; Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Baden D; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel. david.baden@uksh.de.; Zukunft S; Medical Department I, University Hospital of TU Dresden, Dresden.; Hernandez G; TriNetX, TriNetX Europe NV, Sint-Martens-Latem.; Wolgast N; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel.; Steinhauser S; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel.; Pohlmann A; Department of Medicine A, University Hospital Munster.; Schliemann C; Department of Medicine A, University Hospital Munster.; Mikesch JH; Department of Medicine A, University Hospital Munster.; Steffen B; Medical Department II, J.-W.-Goethe University Hospital Frankfurt.; Sauer T; Medical Department V, Heidelberg University Hospital.; Hanoun M; Department of Hematology, Essen University Hospital.; Schafer-Eckart K; Medical Department 5, University Hospital of Paracelsus Medical University Nuremberg.; Krause SW; Department of Medicine 5, Uniklinikum Erlangen.; Hanel M; Department for Internal Medicine III, Klinikum Chemnitz.; Einsele H; Medical Department II, University Hospital Wurzburg.; Jost E; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany and Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Dusseldorf (ABCD), Aachen.; Brummendorf TH; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany and Center for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Dusseldorf (ABCD), Aachen.; Scholl S; Klinik fur Innere Medizin II, Jena University Hospital, Jena.; Hochhaus A; Klinik fur Innere Medizin II, Jena University Hospital, Jena.; Neubauer A; Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg.; Burchert A; Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg.; Kaufmann M; Department of Hematology, Oncology and Palliative Medicine, Robert-Bosch-Hospital Stuttgart.; Niemann D; Internal Medicine, Hematology/Oncology, Palliative Medicine, Gemeinschaftsklinikum Mittelrhein, Koblenz.; Schaich M; Department for Hematology, Oncology and Palliative Medicine, Rems-Murr-Klinikum, Winnenden.; Blau W; Department for Internal Medicine III, Helios Dr Schmidt Hospital Wiesbaden.; Kiani A; Department for Oncology and Hematology, Klinikum Bayreuth, and Comprehensive Cancer Center Erlangen-EMN.; Gorner M; Department for Hematology, Oncology and Palliative Medicine, Klinikum Bielefeld, Bielefeld.; Kaiser U; Medical Department II, St. Bernward Hospital, Hildesheim.; Kullmer J; Medical Department II, Hematology and Oncology, DIAKO Bremen.; Weber T; Department for Internal Medicine IV, University Hospital Halle (Saale).; Berdel WE; Department of Medicine A, University Hospital Munster.; Ehninger G; Medical Department I, University Hospital of TU Dresden, Dresden.; Muller-Tidow C; Medical Department V, Heidelberg University Hospital.; Platzbecker U; Medical Department I, Hematology and Cell Therapy, University Hospital Leipzig.; Serve H; Medical Department II, J.-W.-Goethe University Hospital Frankfurt.; Bornhauser M; Medical Department I, University Hospital of TU Dresden, Dresden.; Rollig C; Medical Department I, University Hospital of TU Dresden, Dresden.; Baldus CD; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel.; Fransecky L; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany; University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Kiel.

Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Kroeze E; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.; Iaccarino I; Kiel University, Kiel, Germany.; Kleisman MM; Princess Maxima Center for Paediatric Oncology, Utrecht, Netherlands.; Mondal M; Kiel University, Kiel, Germany.; Beder T; University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Khouja M; UKSH Kiel, Hämatologie Labor der Spezialdiagnostik, Kiel, Germany.; Höppner MP; Kiel University, Kiel, Germany.; Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Kester LA; Prinses Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Brüggemann M; Universitätsklinikum Schleswig-Holstein, Kiel, Germany.; Baldus CD; University Hospital Schleswig-Holstein, Kiel, Germany.; Cario G; University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Bladergroen RS; Princess Maxima Center for Paediatric Oncology, Utrecht, Netherlands.; Garnier N; Institute of Pediatric Hematology and Oncology, lyon, France.; Attarbaschi A; St. Anna Children's Hospital, Vienna, Austria.; Verdu-Amorós J; Hospital Clínico Universitario de Valencia, valencia, Spain.; Sutton R; Childrens Cancer Institute, Randwick, Australia.; Macintyre EA; Hopital Necker, Université de Paris, Paris, France.; Scholten K; Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany.; Arias Padilla L; Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany.; Burkhardt B; Paediatric Haematology, Oncology and BMT, University Hospital Münster, Münster, Germany.; Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Kuiper RP; Princes Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Loeffen JLC; Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands.; Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Klapper W; Department of Pathology, Kiel, Kiel, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Bastian L; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Beder T; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Barz MJ; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Bendig S; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Bartsch L; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Walter W; MLL Munich Leukemia Laboratory, Munich, Germany.; Wolgast N; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Brändl B; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Department of Psychiatry and Psychotherapy, University Hospital Schleswig Holstein, Kiel, Germany.; Rohrandt C; Department of Psychiatry and Psychotherapy, University Hospital Schleswig Holstein, Kiel, Germany.; Hansen BT; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Hartmann AM; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Iben K; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Das Gupta D; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Denker M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Zimmermann J; Department of Evolutionary Ecology and Genetics, Zoological Institute, Christian Albrechts University, Kiel, Germany.; Wittig M; Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.; Chitadze G; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Neumann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Schneller F; Medical Clinic and Polyclinic of Klinikum rechts der Isar of Technical University Munich, Munich, Germany.; Fiedler W; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Steffen B; Department of Medicine II, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.; Stelljes M; Department of Medicine A-Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Muenster, Munster, Germany.; Faul C; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.; Schwartz S; Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Müller FJ; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Department of Psychiatry and Psychotherapy, University Hospital Schleswig Holstein, Kiel, Germany.; Cario G; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.; Harder L; Institut für Tumorgenetik Nord, Kiel, Germany.; Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany.; Pfeifer H; Department of Medicine II, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.; Gökbuget N; Department of Medicine II, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.; Brüggemann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; Baldus CD; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Burmeister T; Department of Hematology, Oncology and Tumor Immunology, CVK, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. thomas.burmeister@charite.de.; Ströh AS; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Kehden B; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Trautmann H; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Meyer C; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.; Marschalek R; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.; Larghero P; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.; Schwartz S; Department of Hematology, Oncology and Tumor Immunology, CBF, Charité Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Steffen B; Department of Medicine II, Goethe University, University Hospital, Frankfurt, Germany.; Spriewald B; University Hospital Erlangen, Department of Internal Medicine 5, Hematology and Oncology, Erlangen, Germany.; Heinicke T; Department of Hematology and Oncology, Otto-von-Guericke University Hospital, Magdeburg, Germany.; Jäkel N; Department of Hematology, Oncology, University Hospital, Halle/Saale, Germany.; Westermann J; Department of Hematology, Oncology and Tumor Immunology, CVK, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Nachtkamp K; Department of Hematology, Oncology, University Hospital of Düsseldorf, Düsseldorf, Germany.; Viardot A; Department of Hematology, Oncology, University Hospital Ulm, Ulm, Germany.; Topp MS; Department of Hematology, Oncology, University Hospital Würzburg, Würzburg, Germany.; Neumann M; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Baldus CD; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Gökbuget N; Department of Medicine II, Goethe University, University Hospital, Frankfurt, Germany.; Brüggemann M; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Eckardt JN; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. jan-niklas.eckardt@uniklinikum-dresden.de.; Else Kröner Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany. jan-niklas.eckardt@uniklinikum-dresden.de.; Hahn W; Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI) Dresden/Leipzig, Leipzig, Germany.; Institute for Medical Informatics and Biometry, Technical University Dresden, Dresden, Germany.; Röllig C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; Stasik S; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; Platzbecker U; Medical Clinic and Policlinic I Hematology and Cell Therapy, University Hospital, Leipzig, Germany.; Müller-Tidow C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Serve H; Department of Medicine 2, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany.; Baldus CD; Department of Hematology and Oncology, University Hospital Schleswig Holstein, Kiel, Germany.; Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany.; Schäfer-Eckart K; Department of Internal Medicine V, Paracelsus Medizinische Privatuniversität and University Hospital Nürnberg, Nürnberg, Germany.; Hanoun M; Department of Hematology, University Hospital Essen, Essen, Germany.; Kaufmann M; Department of Hematology, Oncology and Palliative Care, Robert-Bosch-Hospital, Stuttgart, Germany.; Burchert A; Department of Hematology, Oncology and Immunology, Philipps-University-Marburg, Marburg, Germany.; Thiede C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; Schetelig J; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; Sedlmayr M; Institute for Medical Informatics and Biometry, Technical University Dresden, Dresden, Germany.; Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; German Consortium for Translational Cancer Research DKFZ, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Dresden, Germany.; Wolfien M; Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI) Dresden/Leipzig, Leipzig, Germany.; Institute for Medical Informatics and Biometry, Technical University Dresden, Dresden, Germany.; Middeke JM; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.; Else Kröner Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101731738 Publication Model: Electronic Cited Medium: Internet ISSN: 2398-6352 (Electronic) Linking ISSN: 23986352 NLM ISO Abbreviation: NPJ Digit Med Subsets: PubMed not MEDLINE

Georgi JA; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Stasik S; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Kramer M; AvenCell Europe GmbH, Dresden, Germany.; Meggendorfer M; MLL Münchner Leukämielabor GmbH, Munich, Germany.; Röllig C; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Haferlach T; MLL Münchner Leukämielabor GmbH, Munich, Germany.; Valk P; Erasmus University Medical Center, Rotterdam, Netherlands.; Linch D; Department of Haematology, UCL Cancer Institute, London, UK.; Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Duployez N; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France.; Taube F; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Middeke JM; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Platzbecker U; Klinik und Poliklinik fur Hämatologie, Zelltherapie und Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany.; Serve H; Medizinische Klinik 2, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany.; Baldus CD; Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.; Muller-Tidow C; Klinik für Hämatologie, Onkologie und Rheumatologie, Universitätsklinikum Heidelberg, Heidelberg, Germany.; Haferlach C; MLL Münchner Leukämielabor GmbH, Munich, Germany.; Koch S; MLL Münchner Leukämielabor GmbH, Munich, Germany.; Berdel WE; Department of Medicine A, University Hospital Münster, Münster, Germany.; Woermann BJ; German Society of Hematology and Oncology, Berlin, Germany.; Krug U; Department of Medicine 3, Klinikum Leverkusen, Leverkusen, Germany.; Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.; Hiddemann W; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Spiekermann K; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Boertjes EL; Erasmus University Medical Center, Rotterdam, Netherlands.; Hills RK; Nuffield Department of Population Health, Oxford University, Oxford, UK.; Burnett A; Department of Haematology, Cardiff University, University Hospital of Wales, Cardiff, UK.; Ehninger G; AvenCell Europe GmbH, Dresden, Germany.; Metzeler K; Klinik und Poliklinik fur Hämatologie, Zelltherapie und Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany.; Rothenberg-Thurley M; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Dufour A; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Dombret H; Hôpital Saint-Louis (AP-HP), EA 3518, Université de Paris, Paris, France.; Pautas C; Service d'Hématologie et de thérapie cellulaire, Hôpital Henri Mondor, Créteil, France.; Preudhomme C; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France.; Fenwarth L; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France.; Bornhäuser M; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Nationales Zentrum für Tumorerkrankungen (NCT), Dresden, Germany.; Gale R; Department of Haematology, UCL Cancer Institute, London, UK.; Thiede C; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. christian.thiede@uniklinikum-dresden.de.; AgenDix GmbH, Dresden, Germany. christian.thiede@uniklinikum-dresden.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE